|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
3
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schuel H, Burkman LJ, Lippes J, Crickard
K, Forester E, Piomelli D and Giuffrida A: N-Acylethanolamines in
human reproductive fluids. Chem Phys Lipids. 121:211–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Devane WA, Hanus L, Breuer A, et al:
Isolation and structure of a brain constituent that binds to the
cannabinoid receptor. Science. 258:1946–1949. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mechoulam R and Hanus L: A historical
overview of chemical research on cannabinoids. Chem Phys Lipids.
108:1–13. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Petrocellis L, Melck D, Palmisano A,
Bisogno T, Laezza C, Bifulco M and Di Marzo V: The endogenous
cannabinoid anandamide inhibits human breast cancer cell
proliferation. Proc Natl Acad Sci USA. 95:8375–8380.
1998.PubMed/NCBI
|
|
8
|
Melck D, De Petrocellis L, Orlando P,
Bisogno T, Laezza C, Bifulco M and Di Marzo V: Suppression of nerve
growth factor Trk receptors and prolactin receptors by
endocannabinoids leads to inhibition of human breast and prostate
cancer cell proliferation. Endocrinology. 141:118–126.
2000.PubMed/NCBI
|
|
9
|
Fowler CJ, Jonsson KO, Andersson A, et al:
Inhibition of C6 glioma cell proliferation by anandamide,
1-arachidonoylglycerol, and by a water soluble phosphate ester of
anandamide: variability in response and involvement of arachidonic
acid. Biochem Pharmacol. 66:757–767. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ligresti A, Bisogno T, Matias I, et al:
Possible endocannabinoid control of colorectal cancer growth.
Gastroenterology. 125:677–687. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miyato H, Kitayama J, Yamashita H, Souma
D, Asakage M, Yamada J and Nagawa H: Pharmacological synergism
between cannabinoids and paclitaxel in gastric cancer cell lines. J
Surg Res. 155:40–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
DeMorrow S, Glaser S, Francis H, Venter J,
Vaculin B, Vaculin S and Alpini G: Opposing actions of
endocannabinoids on cholangiocarcinoma growth: recruitment of Fas
and Fas ligand to lipid rafts. J Biol Chem. 282:13098–13113. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bifulco M, Laezza C, Pisanti S and
Gazzerro P: Cannabinoids and cancer: pros and cons of an antitumour
strategy. Br J Pharmacol. 148:123–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bifulco M and Di Marzo V: Targeting the
endocannabinoid system in cancer therapy: a call for further
research. Nat Med. 8:547–550. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu X, Liu Y, Huang S, et al:
Overexpression of cannabinoid receptors CB1 and CB2 correlates with
improved prognosis of patients with hepatocellular carcinoma.
Cancer Genet Cytogenet. 171:31–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Emanuele S, D’Anneo A, Bellavia G, et al:
Sodium butyrate induces apoptosis in human hepatoma cells by a
mitochondria/caspase pathway, associated with degradation of
beta-catenin, pRb and Bcl-XL. Eur J Cancer. 40:1441–1452. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Youm YS, Lee SY and Lee SH: Apoptosis in
the osteonecrosis of the femoral head. Clin Orthop Surg. 2:250–255.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Labat-Moleur F, Guillermet C, Lorimier P,
Robert C, Lantuejoul S, Brambilla E and Negoescu A: TUNEL apoptotic
cell detection in tissue sections: critical evaluation and
improvement. J Histochem Cytochem. 46:327–334. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao X, Liu G, Xu X, et al: High
expression of vanilloid receptor-1 is associated with better
prognosis of patients with hepatocellular carcinoma. Cancer Genet
Cytogenet. 186:25–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wilson RI and Nicoll RA: Endocannabinoid
signaling in the brain. Science. 296:678–682. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Munson AE, Harris LS, Friedman MA, Dewey
WL and Carchman RA: Antineoplastic activity of cannabinoids. J Natl
Cancer Inst. 55:597–602. 1975.PubMed/NCBI
|
|
22
|
Vara D, Salazar M, Olea-Herrero N, Guzmán
M, Velasco G and Díaz-Laviada I: Anti-tumoral action of
cannabinoids on hepatocellular carcinoma: role of AMPK-dependent
activation of autophagy. Cell Death Differ. 18:1099–1111. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lapenna S and Giordano A: Cell cycle
kinases as therapeutic targets for cancer. Nat Rev Drug Discov.
8:547–566. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Biswas KK, Sarker KP, Abeyama K, et al:
Membrane cholesterol but not putative receptors mediates
anandamide-induced hepatocyte apoptosis. Hepatology. 38:1167–1177.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mimeault M, Pommery N, Wattez N, Bailly C
and Hénichart JP: Anti-proliferative and apoptotic effects of
anandamide in human prostatic cancer cell lines: implication of
epidermal growth factor receptor down-regulation and ceramide
production. Prostate. 56:1–12. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Greenbaum LE: Cell cycle regulation and
hepatocarcinogenesis. Cancer Biol Ther. 3:1200–1207. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hui AM, Makuuchi M and Li X: Cell cycle
regulators and human hepatocarcinogenesis. Hepatogastroenterology.
45:1635–1642. 1998.PubMed/NCBI
|
|
28
|
Nithipatikom K, Isbell MA, Endsley MP,
Woodliff JE and Campbell WB: Anti-proliferative effect of a
putative endocannabinoid, 2-arachidonylglyceryl ether in prostate
carcinoma cells. Prostaglandins Other Lipid Mediat. 94:34–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Laezza C, Pisanti S, Crescenzi E and
Bifulco M: Anandamide inhibits Cdk2 and activates Chk1 leading to
cell cycle arrest in human breast cancer cells. FEBS Lett.
580:6076–6082. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giuliano M, Pellerito O, Portanova P, et
al: Apoptosis induced in HepG2 cells by the synthetic cannabinoid
WIN: involvement of the transcription factor PPARgamma. Biochimie.
91:457–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cory S and Adams JM: The Bcl2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Griffiths GJ, Dubrez L, Morgan CP, et al:
Cell damage-induced conformational changes of the pro-apoptotic
protein Bak in vivo precede the onset of apoptosis. J Cell Biol.
144:903–914. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu LX, Jiang HC, Liu ZH, et al: Gene
expression profiles of hepatoma cell line BEL-7402.
Hepatogastroenterology. 50:1496–1501. 2003.PubMed/NCBI
|
|
34
|
Rousseau B, Ménard L, Haurie V, et al:
Overexpression and role of the ATPase and putative DNA helicase
RuvB-like 2 in human hepatocellular carcinoma. Hepatology.
46:1108–1118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Madesh M and Hajnóczky G: VDAC-dependent
permeabilization of the outer mitochondrial membrane by superoxide
induces rapid and massive cytochrome c release. J Cell Biol.
155:1003–1015. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu R, Zhai Q, Liu W and Liu X: An insight
into the mechanism of cytotoxicity of ricin to hepatoma cell: roles
of Bcl-2 family proteins, caspases, Ca(2+)-dependent proteases and
protein kinase C. J Cell Biochem. 81:583–593. 2001.PubMed/NCBI
|
|
37
|
Wang QF, Chen JC, Hsieh SJ, Cheng CC and
Hsu SL: Regulation of Bcl-2 family molecules and activation of
caspase cascade involved in gypenosides-induced apoptosis in human
hepatoma cells. Cancer Lett. 183:169–178. 2002. View Article : Google Scholar : PubMed/NCBI
|
